Related Experiment Videos
[Pharmacological potentials for activating the fibrinolytic system]
Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
|May 15, 1984
Summary
New thrombolytic therapies are emerging, focusing on vascular endothelium activators and acylated fibrinolytic enzymes. Future treatments aim to control fibrinolysis by targeting plasminogen activator synthesis for hyperfibrinolytic states.
Area of Science:
- Biochemistry
- Pharmacology
- Vascular Biology
Context:
- Thrombolytic therapy has advanced due to a deeper understanding of thrombolysis mechanisms.
- Current therapeutic strategies involve effective thrombolytic agents.
Purpose:
- To explore novel approaches in thrombolytic therapy.
- To identify future directions for enhancing fibrinolytic and thrombolytic treatments.
Summary:
- Progress in thrombolytic therapy is anticipated through the utilization of extrinsic plasminogen activators from vascular endothelium.
- Temporarily blocked (acylated) fibrinolytic enzymes represent another avenue for therapeutic development.
- Further research into fibrinolytic/thrombolytic substances is expected to yield a new generation of fibrinolysis activators.
Impact:
- These advancements aim to interfere with plasminogen activator biosynthesis and release.
- The developed agents are intended for the effective treatment of hyperfibrinolytic states.
- This research contributes to the evolution of treatments for bleeding disorders and thrombosis.